Abstract
Cardiac hypertrophy in response to hyperthyroidism is well known. However, the effects on cardiac microcirculation are still controversial in this model. The present study evaluated the effects of acute administration of two different thyroxine (T4) dose levels on the angiogenic response in the myocardium. Capillary density (CD), the CD to fiber density (FD) ratio (CD/FD), and intercapillary distance (ICD) were assessed, as was ventricle weight (VW) to body weight (BW) ratio (VW/BW). Collagen I and III messenger ribonucleic acid (mRNA) expression and VEGF-A expression were also determined by reverse transcriptase polymerase chain reaction (RT-PCR). Immunohistochemical detection of proliferating cell nuclear antigen (PCNA) expression in endothelial cell nuclei was also carried out. We simulated an acute hyperthyroidism situation in male Wistar rats by daily intraperitoneal injection of T4 (0.025 or 0.1 mg kg−1 day−1) for 7 days. Hemodynamic parameters showed that T4 did not alter systolic blood pressure (SBP) but significantly increased heart rate (HR). Both T4 doses significantly increased VW. Morphologically, the higher T4 dose resulted in a 33% greater myocardial mass, which was not accompanied by alterations in collagen I and III mRNA expression. The CD and CD/FD parameters were significantly lower in the hyperthyroid rats treated with the higher dose than in the control animals, and PCNA-labeling analysis indicated total absence of marked capillary growth. However, although the acute treatment with T4 did not induce any alteration in capillary number and endothelial cell proliferation, the vascular endothelial growth factor (VEGF)-A mRNA and protein expression were significantly increased with the higher T4 dose. These data indicate that the cardiac hypertrophy induced by acute treatment with thyroid hormone precedes the angiogenic process, which probably occurs later.
Similar content being viewed by others
References
Amaral SL, Zorn TMT, Michelini LC (2000) Exercise training normalizes wall-to-lumen ratio of the gracilis muscle arterioles and reduces pressure in spontaneously hypertensive rats. Hypertension 18:1563–1572
Bassett JH, Harvey CB, Williams GR (2003) Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 31:1–11
Bilezikian JP, Loeb JN (1983) The influence of hyperthyroidism and hypothyroidism on α- and β-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev 414:378–387
Breisch AE, White FC, Hammond HK, Flynn S, Bloor CM (1989) Myocardial characteristics of thyroxine stimulated hypertrophy. A structural and functional study. Basic Res Cardiol 84:345–358
Brent GA, Moore DD, Larsen PR (1991) Thyroid hormone regulation of gene expression. Annu Rev Physiol 53:17–35
Carneiro-Ramos MS, Silva VB, Coutinho-Junior MB, Battastini AMO, Sarkis JJF, Barreto-Chaves MLM (2004) Thyroid hormone stimulates 5′-ecto-nucleotidase of neonatal rat ventricular myocytes. Mol Cell Biochem 265:195–201
Chilian WM, Wangler RD, Peters KG, Tomanek RJ, Marcus ML (1985) Thyroxine-induced left ventricular hypertrophy in the rat. Anatomical and physiological evidence for angiogenesis. Circ Res 57:591–598
Craft-Cormney C, Hansen JT (1980) Early ultrastructural changes in the myocardium following thyroxine-induced hypertrophy. Virchows Arch B Cell Pathol 33:267–273
Davis PJ, Davis FB (2002) Nongenomic actions of thyroid hormone on the heart. Thyroid 12:459–66
Egginton S and Turek S (1990) Comparative distributions of numerical and areal indices of tissue capillarity. Adv Exp Med Biol 277:161–169
Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581–611
Gerdes AM, Callas G, Kasten FH (1979) Differences in regional capillary distribution and myocytes size in normal and hypertrophic rat heart. Am J Anat 156:523–532
Heron MI, Rakusan K (1995) Proliferating cell nuclear antigen (PCNA) detection of cellular proliferation in hypothyroid and hyperthyroid rats hearts. J Mol Cell Cardiol 27(7):1393–1403
Hu LW, Benvenuti LA, Liberti EA, Carneiro-Ramos MS, Barreto-Chaves ML (2003) Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am J Physiol Regul Integr Comp Physiol 285(6):R1473–R1480
Hu LW, Liberti EA, Barreto-Chaves ML (2005) Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormone-an acute study in rats. Virchows Arch 446:265–269
Kavok NS, Krasilnikova OA, Babenko NA (2001) Thyroxine signal transduction in liver cells involves phospholipase C and phospholipase D activation. Genomic independent action of thyroid hormone. BMC Cell Biol 2:5
Kobori H, Ichihara A, Miyashita Y, Hayashi M, Saruta T (1999) Local renin–angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. J Endocrinol 160:43–47
Lindpaintner K, Lu W, Neidermajer N, Schicffer B, Just H, Ganten D, Drexler H (1993) Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol 25:133–143
Morgan HE, Kenneth M, Baker MD (1991) Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation 83:13–24
Nagy JA, Dvorak AM, Dvorak HF (2003) VEGF-A164/165 and PlGF. Roles in angiogenesis and arteriogenesis. TCM 13(5):169–175
Olivetti G, Anversa P, Loud AV (1980) Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. II. Tissue composition capillary growth, and sarcoplasmic alterations. Circ Res 46:503–512
Pepper MS (1997) Manipulating angiogenesis: from basic science to the bedside. Arterioscler Thromb Vasc Biol 17:605–619
Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9:677–84
Rakusan K, Cicutti N, Flanagan MF (1994) Changes in the microvascular network during cardiac growth, development and aging. Cell Mol Biol Res 40(2):117–22
Ribatti D (2004) The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review. Br J Haematol 128:303–309
Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115:2108–2118
Tanaka E, Hattan N, Ando K, Ueno H, Sugio Y, Mohammed MU, Voltchikhina SA, Mori H (2000) Amelioration of microvascular myocardial ischemia by gene transfer of vascular endothelial growth factor in rabbits. J Thorac Cardiovasc Surg 120(4):720–728
Tomanek RJ, Connell PM, Butters CA, Torry RJ (1995) Compensated coronary microvascular growth in senescent rats with thyroxine-induced cardiac hypertrophy. Am J Physiol 268:H419–H425
Tomanek RJ, Searls JC, Lachenbruch PA (1982) Quantitative changes in the capillary bed during developing peak and stabilized hypertrophy in a spontaneously hypertensive rat. Circ Res 51:295–304
Tsai MJ, O’Malley BW (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Ann Rev Biochem 63:451–486
Waltenberger J (2005) Growth factor signal transduction defects in the cardiovascular system. Cardiovasc Res 65:574–580
Weiss HR, Grover GJ (1987) T4-induced cardiac hypertrophy and the perfused and total microvasculature of the heart. Can J Physiol Pharmacol 65:1848–1855
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Anjos-Ramos, L., Carneiro-Ramos, M.S., Diniz, G.P. et al. Early cardiac hypertrophy induced by thyroxine is accompanied by an increase in VEGF-A expression but not by an increase in capillary density. Virchows Arch 448, 472–479 (2006). https://doi.org/10.1007/s00428-005-0140-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-005-0140-y